McKesson Corporation (NYSE: MCK) Stock Competitors & Peer Comparison
See MCK's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MCK and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MCK | $866.64 | -0.31% | 101.5B | 21.23 | $40.82 | +0.39% |
| COR | $306.92 | -0.95% | 59.7B | 17.90 | $17.15 | +0.78% |
| CAH | $220.22 | -1.08% | 51.6B | 21.11 | $10.43 | +0.93% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $86.37 | +0.98% | 9.8B | 16.27 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| AHG | $0.75 | -1.32% | 640.5M | -3.51 | -$0.21 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| EMPG | $17.36 | +0.00% | 143M | 192.89 | $0.09 | N/A |
| ACH | $0.71 | -3.44% | 54.7M | 1.05 | $0.68 | N/A |
Stock Comparison
Cencora, Inc. (NYSE: COR)
MCK vs COR Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, COR has a market cap of 59.7B. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while COR trades at $306.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas COR's P/E ratio is 17.90. In terms of profitability, MCK's ROE is -1.94%, compared to COR's ROE of +1.06%. Regarding short-term risk, MCK is less volatile compared to COR. This indicates lower risk in terms of short-term price fluctuations for MCK.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
MCK vs CAH Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, CAH has a market cap of 51.6B. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while CAH trades at $220.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas CAH's P/E ratio is 21.11. In terms of profitability, MCK's ROE is -1.94%, compared to CAH's ROE of -0.60%. Regarding short-term risk, MCK is less volatile compared to CAH. This indicates lower risk in terms of short-term price fluctuations for MCK.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
MCK vs ABC Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas ABC's P/E ratio is 21.92. In terms of profitability, MCK's ROE is -1.94%, compared to ABC's ROE of +1.06%. Regarding short-term risk, MCK is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for MCK.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
MCK vs HSIC Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, HSIC has a market cap of 9.8B. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while HSIC trades at $86.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas HSIC's P/E ratio is 16.27. In terms of profitability, MCK's ROE is -1.94%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, MCK is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for MCK.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
MCK vs PDCO Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas PDCO's P/E ratio is 20.48. In terms of profitability, MCK's ROE is -1.94%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, MCK is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for MCK.Check PDCO's competition here
Akso Health Group (NASDAQ: AHG)
MCK vs AHG Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, AHG has a market cap of 640.5M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while AHG trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas AHG's P/E ratio is -3.51. In terms of profitability, MCK's ROE is -1.94%, compared to AHG's ROE of -0.50%. Regarding short-term risk, MCK is less volatile compared to AHG. This indicates lower risk in terms of short-term price fluctuations for MCK.Check AHG's competition here
Owens & Minor, Inc. (NYSE: OMI)
MCK vs OMI Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas OMI's P/E ratio is -0.47. In terms of profitability, MCK's ROE is -1.94%, compared to OMI's ROE of +0.63%. Regarding short-term risk, MCK is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for MCK.Check OMI's competition here
Empro Group Inc. Ordinary shares (NASDAQ: EMPG)
MCK vs EMPG Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, EMPG has a market cap of 143M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while EMPG trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas EMPG's P/E ratio is 192.89. In terms of profitability, MCK's ROE is -1.94%, compared to EMPG's ROE of +0.66%. Regarding short-term risk, MCK is more volatile compared to EMPG. This indicates higher risk in terms of short-term price fluctuations for MCK.Check EMPG's competition here
Accendra Health, Inc. (NYSE: ACH)
MCK vs ACH Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, ACH has a market cap of 54.7M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while ACH trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas ACH's P/E ratio is 1.05. In terms of profitability, MCK's ROE is -1.94%, compared to ACH's ROE of +0.63%. Regarding short-term risk, MCK is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for MCK.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
MCK vs HX Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas HX's P/E ratio is -1.84. In terms of profitability, MCK's ROE is -1.94%, compared to HX's ROE of -1.07%. Regarding short-term risk, MCK is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for MCK.Check HX's competition here
111, Inc. (NASDAQ: YI)
MCK vs YI Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, YI has a market cap of 34.3M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while YI trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas YI's P/E ratio is -2.37. In terms of profitability, MCK's ROE is -1.94%, compared to YI's ROE of +0.24%. Regarding short-term risk, MCK is more volatile compared to YI. This indicates higher risk in terms of short-term price fluctuations for MCK.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
MCK vs WGRX Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas WGRX's P/E ratio is -0.33. In terms of profitability, MCK's ROE is -1.94%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, MCK is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for MCK.Check WGRX's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
MCK vs MEDS Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, MEDS has a market cap of 8.2M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while MEDS trades at $3.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas MEDS's P/E ratio is N/A. In terms of profitability, MCK's ROE is -1.94%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, MCK is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for MCK.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
MCK vs ZYXI Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, MCK's ROE is -1.94%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, MCK is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for MCK.Check ZYXI's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
MCK vs HKPD Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, HKPD has a market cap of 1.2M. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while HKPD trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas HKPD's P/E ratio is -1.60. In terms of profitability, MCK's ROE is -1.94%, compared to HKPD's ROE of -0.15%. Regarding short-term risk, MCK is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for MCK.Check HKPD's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
MCK vs SNYR Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, SNYR has a market cap of 941.8K. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while SNYR trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas SNYR's P/E ratio is -0.06. In terms of profitability, MCK's ROE is -1.94%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, MCK is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for MCK.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
MCK vs RDGT Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, RDGT has a market cap of 726K. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while RDGT trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas RDGT's P/E ratio is -0.01. In terms of profitability, MCK's ROE is -1.94%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, MCK is less volatile compared to RDGT. This indicates lower risk in terms of short-term price fluctuations for MCK.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
MCK vs CVET Comparison September 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 101.5B. In comparison, CVET has a market cap of 0. Regarding current trading prices, MCK is priced at $866.64 on the NYSE, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 21.23, whereas CVET's P/E ratio is -69.97. In terms of profitability, MCK's ROE is -1.94%, compared to CVET's ROE of -0.06%. Regarding short-term risk, MCK is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for MCK.Check CVET's competition here